220
Views
28
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases

, , , &
Pages 2187-2195 | Received 11 Jun 2008, Accepted 06 Sep 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhi-Gang Zhao, Zeng Cao, Wen Xu, Li Sun, Yong You, Fang Li, Qiu-Bai Li & Ping Zou. (2012) Immune Protection Function of Multipotent Mesenchymal Stromal Cells: Role of Transforming Growth Factor-β1. Cancer Investigation 30:9, pages 646-656.
Read now
Matthew D Scaife, Anton Neschadim, DH Fowler & JA Medin. (2009) Novel application of lentiviral vectors towards treatment of graft-versus-host disease. Expert Opinion on Biological Therapy 9:6, pages 749-761.
Read now

Articles from other publishers (26)

Charalampos G. Pontikoglou, Angelos Matheakakis & Helen A. Papadaki. (2023) The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting. Frontiers in Oncology 13.
Crossref
Moaz Safwan, Mariam Safwan Bourgleh, Hani Alshakaki, Abdullah Molhem & Khawaja Husnain Haider. 2023. Handbook of Stem Cell Applications. Handbook of Stem Cell Applications 1 29 .
Likun Zheng, Lei Zhang, Yixuan Guo, Xintong Xu, Zhaoyun Liu, Zhenyu Yan & Rong Fu. (2022) The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome. Frontiers in Immunology 13.
Crossref
Jaquelyn T. Zoine, Sarah E. Moore & M. Paulina Velasquez. (2022) Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy. Frontiers in Immunology 13.
Crossref
Suncica Kapor & Juan F. Santibanez. (2021) Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies. Journal of Clinical Medicine 10:13, pages 2788.
Crossref
Samanta Romina Zanetti, Paola Alejandra Romecin, Meritxell Vinyoles, Manel Juan, José Luis Fuster, Mireia Cámos, Sergi Querol, Mario Delgado & Pablo Menendez. (2020) Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity. Journal for ImmunoTherapy of Cancer 8:2, pages e001419.
Crossref
Bruno Fattizzo, Juri A. Giannotta & Wilma Barcellini. (2020) Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk. International Journal of Molecular Sciences 21:15, pages 5438.
Crossref
Roberta Andrejew, Talita Glaser, Ágatha Oliveira-Giacomelli, Deidiane Ribeiro, Mariana Godoy, Alessandro Granato & Henning Ulrich. 2019. Stem Cells. Stem Cells 275 353 .
Giulia Corradi, Carmen Baldazzi, Darina Očadlíková, Giovanni Marconi, Sarah Parisi, Nicoletta Testoni, Carlo Finelli, Michele Cavo, Antonio Curti & Marilena Ciciarello. (2018) Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Stem Cell Research & Therapy 9:1.
Crossref
Matheus Rodrigues Lopes, João Kleber Novais Pereira, Paula de Melo Campos, João Agostinho Machado-Neto, Fabiola Traina, Sara T. Olalla Saad & Patricia Favaro. (2017) De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Scientific Reports 7:1.
Crossref
Nicola Stefano Fracchiolla, Bruno Fattizzo & Agostino Cortelezzi. (2017) Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications. Stem Cells International 2017, pages 1-13.
Crossref
M. Qayed, I. Copland & J. Galipeau. 2017. Mesenchymal Stromal Cells. Mesenchymal Stromal Cells 97 120 .
Lisa Pleyer, Peter Valent & Richard Greil. (2016) Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?. International Journal of Molecular Sciences 17:7, pages 1009.
Crossref
Francesca Chiarini, Annalisa Lonetti, Camilla Evangelisti, Francesca Buontempo, Ester Orsini, Cecilia Evangelisti, Alessandra Cappellini, Luca M. Neri, James A. McCubrey & Alberto M. Martelli. (2016) Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:3, pages 449-463.
Crossref
Somayeh Ebrahimi-Barough, Reza Rahbarghazi, Zohreh Bagher, Jafar Ai & Elham Hoveizi. 2016. Perinatal Tissue-Derived Stem Cells. Perinatal Tissue-Derived Stem Cells 107 136 .
Elin Hallan Naderi, Seham Skah, Hege Ugland, Ola Myklebost, Dagny Lise Sandnes, Maria Lyngaas Torgersen, Dag Josefsen, Ellen Ruud, Soheil Naderi & Heidi Kiil Blomhoff. (2015) Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death. Molecular Cancer 14:1.
Crossref
Binsheng Wang, Yongxian Hu, Lizhen Liu, Kaimin Hu, Ruxiu Tie, Ying He, Shan Fu, Ni Zhu, Yi Luo, Xiaohong Yu & He Huang. (2015) Phenotypical and Functional Characterization of Bone Marrow Mesenchymal Stem Cells in Patients with Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 21:6, pages 1020-1028.
Crossref
Rebecca S. Y. Wong & Soon-Keng Cheong. (2013) Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde?. Clinical and Experimental Medicine 14:3, pages 235-248.
Crossref
Fernanda Marconi RoversiMatheus Rodrigues LopesJoão Agostinho Machado-NetoAna Leda F. LonghiniAdriana da Silva Santos DuarteMariana Ozello BarattiBruna PalodettoFlávia Adolfo CorrocherFernando Vieira PericolePaula de Melo CamposPatricia FavaroFabiola TrainaSara Teresinha Olalla Saad. (2014) Serine Protease Inhibitor Kunitz-Type 2 Is Downregulated in Myelodysplastic Syndromes and Modulates Cell–Cell Adhesion. Stem Cells and Development 23:10, pages 1109-1120.
Crossref
Maria-Christina Kastrinaki, Konstantia Pavlaki, Aristea K. Batsali, Elisavet Kouvidi, Irene Mavroudi, Charalampos Pontikoglou & Helen A. Papadaki. (2013) Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes. Clinical and Developmental Immunology 2013, pages 1-10.
Crossref
J. Grassinger & R. Schelker. 2013. Evolution-adjusted Tumor Pathophysiology:. Evolution-adjusted Tumor Pathophysiology: 69 90 .
Zhi-Gang Zhao, Wen Xu, Hai-Peng Yu, Bing-Ling Fang, Shu-Hong Wu, Fang Li, Wei-Min Li, Qiu-Bai Li, Zhi-Chao Chen & Ping Zou. (2012) Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes. Cancer Letters 317:2, pages 136-143.
Crossref
Charalampos Pontikoglou, Frédéric Deschaseaux, Luc Sensebé & Helen A. Papadaki. (2011) Bone Marrow Mesenchymal Stem Cells: Biological Properties and Their Role in Hematopoiesis and Hematopoietic Stem Cell Transplantation. Stem Cell Reviews and Reports 7:3, pages 569-589.
Crossref
Bambang Ardianto, Takeshi Sugimoto, Seiji Kawano, Shimpei Kasagi, Siti NA Jauharoh, Chiyo Kurimoto, Eiji Tatsumi, Keiko Morikawa, Shunichi Kumagai & Yoshitake Hayashi. (2010) The HPB-AML-I cell line possesses the properties of mesenchymal stem cells. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
A J Barrett & K Le Blanc. (2010) Immunotherapy prospects for acute myeloid leukaemia. Clinical and Experimental Immunology 161:2, pages 223-232.
Crossref
Mirjam KlausEmily StavroulakiMaria-Christina KastrinakiPersefoni FragioudakiKrinio GiannikouMaria PsyllakiCharalampos PontikoglouDebbie TsoukatouClio MamalakiHelen A Papadaki. (2010) Reserves, Functional, Immunoregulatory, and Cytogenetic Properties of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes. Stem Cells and Development 19:7, pages 1043-1054.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.